Codexis licenses biomanufacturing technology for $10 million, to improve enzyme production cycle time

In Florida, Dyadic International announced that it has licensed its biomanufacturing technology to Codexis for $10 million. Codexis said that it would use the technology in conjunction with its synthetic enzymes for cellulosic ethanol production under a deal between Codexis and Shell.

Dyadic’s C-1 fungus (Chrysosporium lucknowense), which is licensed on a non-exclusive basis to Abengoa Energy and other companies in addition to Codexis, speeds up the process of synthetic enzyme production and makes cellulosic ethanol production more commercially viable.

Free Subscription to the Daily Biofuels Digest e-newsletter

Related Stories

Shell purchases stake in Codexis, an enzyme manufacturer for cellulosic ethanol

Shell has purchased an undisclosed stake in stake in Codexis, a company which manufactures enzymes for the cellulosic ethanol production process. Codexis executives said that they expect to build a co...

Dyadic receives last installment in $10 million payment from Codexis for enzyme production system

In Florida, Dyadic filed an SEC 8-K form confirming that the company has received the final installment in $10 million in upfront payments from Codexis for a license to utilize "the use of Dyadic's C1...

Codexis CEO: “We’re hitting escape velocity” as Shell deepens ties to enzymes pioneer

At WBM 2009, Codexis CEO Alan Shaw offered more details on the company's expansion, including a new investment from Shell Oil rumored to be on the $30 million scale. "In a way, Shell is like IBM and w...

Enzyme, gene expression leader Dyadic files suit against legal counsel

In Florida, upheaval continues at enzyme biotechnology company Dyadic. Founder and CEO Mark Emelfarb, who regained control of the company last summer after a proxy fight, has filed suit against Ern...

Shell Oil to expand investment in Codexis, adds one more board seat; Codexis to further optimize Shell-Iogen cellulosic ethanol biocatalysts

In California, Codexis announced that it has received an increased investment from Shell to accelerate its development timetable for commercial biofuels. The company said that Shell will also take an ...

FDA approves Syngenta’s new corn seed for bulk trial; first seed to contain the vital corn amylase enzyme

In Washington, the FDA approved bulk trials of a new corn seed from Syngenta which contains the corn amylase enzyme, after positive results from pilot trials. The Anglo-Swiss group company said that i...